Terminated PHASE4 INTERVENTIONAL 2-arm NCT00722436

Tranexamic Acid for Craniofacial Surgery

Tranexamic Acid for the Reduction of Allogeneic Blood Exposure in Infants and Children Having Craniofacial Surgery

Sponsor: University of Pittsburgh

Updated 9 times since 2017 Last updated: Feb 10, 2017 Started: Jul 31, 2008 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study dose changed based on recent publications

Other terminated trials from University of Pittsburgh

See all terminations from University of Pittsburgh

Other Bleeding trials with similar outcome

Browse all Bleeding trials

This PHASE4 trial investigates Bleeding and Craniosynostosis and is currently terminated or withdrawn. University of Pittsburgh leads this study, which shows 9 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States